Abstract
Drew Pardoll (Johns Hopkins Oncology Center) examines prospects for therapeutic cancer vaccines. Considering how it is that the immune system fails to recognize and destroy cancer cells, Pardoll discusses contemporary vaccine approaches aimed at exposing cancer antigens to the cellular arm of the immune system, and the first, promising steps toward therapeutic cancer vaccines.
Similar content being viewed by others
Article PDF
References
Nauts, H.C. Cancer Surv. 8, 713–723 (1989).
Thomas, L. In Discussion of cellular and humoral aspects of the hypersensitive states. pages 529–532 (Hoeber-Harper, New York, 1959).
Burnet, F.M. Prog. Exp. Tumor Res. 13, 1–27 (1970).
Urban, J.L., Burton, R.C., Holland, J.M., Kripke, M.L. & H. J. Exp. Med. 155, 557–573 (1982).
Uyttenhove, C., Maryanski, J. & Boon, T. T. J. Exp. Med. 157, 1040–1052 (1983).
Wortzel, R.D., Philipps, C. & Schreiber, H. Nature 304, 165–167 (1983).
Hui, K., Grosveld, F. & Festenstein, H. Nature 311, 750–752 (1984).
Wallich, R. et al. Nature 315, 301–305 (1985).
Haywood, G.R. & McKhann, C.F. J. Exp. Med. 133, 1171–1187 (1971).
Trowsdale, J., Travers, P., Bodmer, W.F. & Patillo, R.A. J. Exp. Med. 152, 11s–17s (1980).
Restifo, N.P. et al. J. Immunol. 147, 1453–1459 (1991).
Torre, A.G. et al. Proc. Natl. Acad. Sci. USA 87, 1486–1490 (1990).
Hahne, M. et al. Science 274, 1363–1366 (1996).
Ohashi, P.S. et al. Cell 65, 305–317 (1991).
Miller, J.F., Morahan, G. & Allison, J. Cold Spring Harb. Symp. Quant. Biol. 2, 807–813 (1989).
Burkly, L.C., Lo, D., Kanagawa, O., Brinster, R.L. & Flavell, R.A. Nature 342, 564–566 (1989).
Staveley-O'Carroll, K. et al. Proc. Natl. Acad. Sci. USA 95, 1178–1183 (1998).
Wick, M. et al. J. Exp. Med. 186, 229–238 (1997).
Speiser, D.E. et al. J. Exp. Med. 186, 645–653 (1997).
Nanda, N.K. & Sercarz, E.E. Cell 82, 13–17 (1995).
Huang, A.Y. et al. Science 264, 961–965 (1994).
Kovacsovics-Bankowski, M. & Rock, K.L. Science 267, 243–246 (1995).
Huang, A.Y.C., Bruce, A.T., Pardoll, D.M. & Levitsky, H.I. Immunity 4, 349–355 (1996).
Albert, M.L., Sauter, B. & J. Nature 392, 86–89 (1998).
Golumbek, P.T. et al. Science 254, 713–716 (1991).
Dranoff, G. et al. Proc. Natl. Acad. Sci. USA 90, 3539–3543 (1993).
Ostrand-Rosenberg, S. Curr. Opin. Immunol. 6, 722–727 (1994).
Topalian, S.L. et al. Proc. Natl. Acad. Sci. USA 91, 9461–9465 (1994).
Tepper, R.I., Pattengale, P.K. & Leder, P. Cell 57, 503–512 (1989).
Wolfel, T. et al. Science 269, 1281–1284 (1995).
Rubinfeld, B. et al. Science 275, 1790–1792 (1997).
Mandruzzato, S. J. Exp. Med. 186, 785–793 (1997).
Prehn, R.T. J. Natl. Cancer Inst. 18, 769–778 (1957).
Van der Eynde, B., Lethe, B., Vel Pel, A., De Plaen, E. & Boon, T. J. Exp. Med. 173, 1373–1384 (1991).
Huang, A.Y.C. et al. Proc. Natl. Acad. Sci. USA 93, 9730–9735 (1996).
Van Pel, A. et al. Immunol. Rev. 145, 229–250 (1995).
Rosenberg, S.A., Kawakami, Y., Robbins, P.F. & Wang, R.F. Adv. Cancer Res. 70, 145–177 (1996).
Robbins, P.F. & Kawakami, Y. Current Opinion in Immunology 8, 628–636 (1996).
Cox, A.L. et al. Science 264, 716–719 (1994).
Kawakami, Y. et al. Proc. Natl. Acad. Sci. USA 91, 6458–6462 (1994).
Coulie, P.G. et al. J. Exp. Med. 180, 35–12 (1994).
Bishop, J.M. Cell 64, 235–248 (1991).
Hunter, T. Cell 64, 249–270 (1991).
Nigro, J.M. et al. Nature 342, 705–708 (1989).
Vierboom, M.P. et al. J. Exp. Med. 186, 695–704 (1997).
Disis, M.L. & Cheever, M.A. Oncogenic proteins as tumor antigens. Current Opinion in Immunology 8, 637–642 (1996).
Slamon, D.J. et al. Science 244, 707–712 (1989).
Brossart, P. et al. Cancer Res. 58, 732–736 (1998).
Katsumata, M. et al. Nature Med. 1, 644–648 (1995).
Beasley, R.P., Hwang, L.Y., Lin, C.C. & Chien, C.S. Lancet 2, 1129–1133 (1981).
Gissmann, L. & Schwarz, E. Ciba Found Symp. 120, 190–207 (1986).
Beaudenon, S. et al. Nature 321, 246–249 (1986).
Ressing, M.E. et al. Cancer Res. 56, 582–588 (1996).
De Gruijl, T.D. et al. J. Cen. Virol. 77, 2183–2191 (1996).
Chang, M.H. et al. New Engl. J. Med. 336, 1855–1859 (1997).
Livingston, P.O. et al. Cancer 55, 713–720 (1985).
Berd, D., Maguire, H.C.J., McCue, P. & Mastrangelo, M.J. J. Clin. Oncol. 8, 1858–1867 (1990).
Lindenmann, J. & Klein, P.A. J. Exp. Med. 126, 93–108 (1967).
Fearon, E.R., Itaya, T., Hunt, B., Vogelstein, B. & Frost, P. Cancer Res. 48, 2975–2980 (1988).
Itaya, T. et al. Cancer Res. 47, 3136–3140 (1987).
Plautz, G.E. et al. Proc. Natl. Acad. Sci. USA 90, 4645–4649 (1993).
Pardoll, D. Ann. Rev. Immunol. 13, 399–415 (1995).
Banchereau, J. & Steinman, R.M. Nature 392, 245–252 (1998).
Simons, J.W. et al. Cancer Res. 57, 1537–1546 (1997).
Golumbek, P.T. et al. Cancer Res. 53, 1–4 (1993).
Thomas, M.C., Greten, T.F., Pardoll, D.M. & Jaffee, E.M. Human Gene Ther. in the press.
Toes, R.E. et al. Cancer Res. 56, 3782–3787 (1996).
Schulz, M., Zinkernagel, R.M. & Hengartner, H. Proc. Natl. Acad. Sci. USA 88, 991–993 (1991).
Kast, W.M. et al. Proc. Natl. Acad. Sci. USA 88, 2283–2387 (1991).
Feltkamp, M.C. et al. Eur. J. Immunol. 23, 2242–2249 (1993).
Aichele, P., Brduscha, R.K., Zinkernagel, R.M., Hengartner, H. & Pircher, H. J. Exp. Med. 182, 261–266 (1995).
Toes, R.E., Blom, R.J., Offringa, R., Kast, W.M. & Melief, C.J. J. Immunol. 156, 3911–3918 (1996).
Marchand, M. et al. Int. J. Cancer 63, 883–885 (1995).
Rosenberg, S.A. et al. Nature Med. 4, 321–327 (1998).
Parkhurst, M.R. et al. J Immunol 157, 2539–2548 (1996).
Moss, B., Smith, G.L., Gerin, J.L. & Purcell, R.H. Nature 311, 67–69 (1984).
Cox, W.I., Tartaglia, J. & Paoletti, E. . In Recombinant poxviruses (eds. Binns, M. & Smith, G.L.) 123–162 (CRC Press, Boca Raton, FL, 1992).
Lathe, R. et al. Nature 326, 878–880 (1987).
Bernards, R. et al. Proc. Natl. Acad. Sci. USA 84, 6854–6858 (1987).
Wang, M. et al. J. Immunol. 154, 4685–4692 (1995).
Juillard, V. et al. Eur. J. Immunol. 25, 3467–3473 (1995).
Chen, P.W. et al. J. Immunol. 156, 224–231 (1996).
Xiang, Z.Q., Yang, Y., Wilson, J.M. & Ertl, H.C. Virology 219 (1996).
Minev, B.R., McFarland, B.J., Spiess, P.J., Rosenberg, S.A. & Restifo, N.P. Cancer Res. 54, 4155–4161 (1994).
Wu, T.C. et al. Proc. Natl. Acad. Sci. USA 92, 11671–11675 (1995).
Lin, K.Y. et al. Cancer Res. 56, 21–26 (1996).
Bronte, V. et al. J. Immunol. 154, 5282–5292 (1995).
Borysiewicz, L.K. et al. Lancet 347, 1523–1527 (1996).
Hoiseth, S.K. & Stocker, B.A. Nature 291, 238–239 (1981).
Poirier, T.P., Kehoe, M.A. & Beachey, E.H. J. Exp. Med. 168, 25–32 (1988).
Sadoff, J.C. et al. Science 240, 336–338 (1988).
Stover, C.K. et al. Nature 351, 456–460 (1991).
Aldovini, A. & Young, R.A. Nature 351, 479–482 (1991).
Schafer, R., Portnoy, D.A., Brassell, S.A. & Paterson, Y. J. Immunol. 149, 53–59 (1992).
Ikonomidis, G., Paterson, Y., Kos, F.J. & Portnoy, D.A. J. Exp. Med. 180, 2209–2218 (1994).
Pan, Z.K., Ikonomidis, G., Lazenby, A., Pardoll, D.M. & Paterson, Y. Nature Med. 1, 471–477 (1995).
Pan, Z.K., Ikonomidis, G., Pardoll, D. & Paterson, Y. Cancer Res. 55, 4776–4779 (1995).
Falkow, S., Isberg, R.R. & Portnoy, D.A. Annu. Rev. Cell Biol. 8, 333–363 (1992).
Newborg, M.F. & North, R.J. J. Immunol. 124, 571–576 (1980).
Portnoy, D.A. Curr. Opin. Immunol. 4, 20–24 (1992).
Montgomery, D.L. et al. DNA Cell Biol. 12, 777–783 (1993).
Irvine, K.R. et al. J. Natl. Cancer Inst. 89, 1595–1601 (1997).
Pardoll, D.M. & Beckerleg, A.M. Immunity 3, 165–169 (1995).
Fu, T.M. et al. Mol. Med. 3, 362–371 (1997).
Sato, Y. et al. Science 273, 352–354 (1996).
Weiner, G.J., Liu, H.M., Wooldridge, J.E., Dahle, C.E. & Krieg, A.M. Proc. Natl. Acad. Sci. USA 94, 10833–10837 (1997).
Chace, J.H., Hooker, N.A., Mildenstein, K.L., Krieg, A.M. & Cowdery, J.S. Clin. Immunol. Immunopathol. 84, 185–193 (1997).
Adema, G.J. et al. Nature 387, 713–717 (1997).
Mayordomo, J.I. et al. Nature Med. 1, 1297–1302 (1995).
Hsu, F.J. et al. Nature Med. 2, 52–58 (1996).
Paglia, P., Chiodoni, C., Rodolfo, M. & Colombo, M.P. J. Exp. Med. 183, 317–322 (1996).
Gong, J., Chen, D., Kashiwaba, M. & Kufe, D. Nature Med. 3, 558–561 (1997).
Boczkowski, D., Nair, S.K., Snyder, D. & Gilboa, E. J. Exp. Med. 184, 465–472 (1996).
Specht, J.M. et al. J. Exp. Med. 186, 1213–1221 (1997).
Song, W. et al. J. Exp. Med. 186, 1247–1256 (1997).
Hsu, F.J. et al. Nature Med. 2, 52–58 (1996).
Nestle, F.O. et al. Nature Med. 4, 328–332 (1998).
Srivastava, P.K. & Heike, M. Semin. Immunol. 3, 57–64 (1991).
Udono, H., Levey, D.L. & Srivastava, P.K. Proc. Natl. Acad. Sci. USA 91, 3077–3081 (1994).
Lammert, E. et al. Eur. J. Immunol. 27, 923–927 (1997).
Tamura, Y., Peng, P., Liu, K., Daou, M. & Srivastava, P.K. Science 278, 117–120 (1997).
Suzue, K., Zhou, X., Eisen, H.N. & Young, R.A. Proc. Natl. Acad. Sci. USA 94, 13146–13151 (1997).
Villanueva, M.S., Fischer, P., Feen, K. & Pamer, E.G. Immunity 1, 479–89 (1994).
Krummel, M.F. & Allison, J.P. J. Exp. Med. 183, 2533–2540 (1996).
Waterhouse, P. et al. Science 270, 985–988 (1995).
Tivol, E.A. et al. Immunity 3, 541–547 (1995).
Leach, D.R., Krummel, M.F. & Allison, J.P. Science 271, 1734–1736 (1996).
Kwon, E.D. et al. Proc. Natl. Acad. Sci. USA 94, 8099–8103 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pardoll, D. Cancer vaccines. Nat Med 4 (Suppl 5), 525–531 (1998). https://doi.org/10.1038/nm0598supp-525
Issue Date:
DOI: https://doi.org/10.1038/nm0598supp-525
This article is cited by
-
Vaccines as treatments for prostate cancer
Nature Reviews Urology (2023)
-
Cancer combination therapies by angiogenesis inhibitors; a comprehensive review
Cell Communication and Signaling (2022)
-
Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier
Cancer Cell International (2022)
-
Biomedical polymers: synthesis, properties, and applications
Science China Chemistry (2022)
-
Identification and Design of a Next-Generation Multi Epitopes Bases Peptide Vaccine Candidate Against Prostate Cancer: An In Silico Approach
Cell Biochemistry and Biophysics (2020)